Diet
Otherlow carbohydrate diet (< 10 EN% carbs) vs high carbohydrate diet (>50 EN% carbs)
NCT Number: NCT04019730
comparing the exercise induced immune response after two weeks on a low carbohydrate (ketogenic) diet with the response after two weeks on a high carbohydrate diet.
Looking for future studies?
Notify Me18 year–45 year
Male
Interventional
Not applicable
Division of Human Nutrition, Wageningen University, Wageningen, Gelderland, Netherlands
A cross-over intervention study, with a total duration of 6 weeks. An athlete follows a high, or low carbohydrate (ketogenic) diet. After 2 days a test day takes place where the athlete performs an exercise test and blood samples are taken at different time points. After that, the athlete continues following the diet for another 12 days, after which he comes back again for another identical test day. Then a 2 weeks wash-out period. After that, the athlete follows the same protocol but then with either the low (ketogenic), or high carbohydrate diet.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
low carbohydrate diet (< 10 EN% carbs) vs high carbohydrate diet (>50 EN% carbs)
Time frame: after 2 days and 2 weeks of adapted diet
blood samples will be collected before and after exercise, the % of T-cells, NK-T-cells, B-cells, Monocytes in blood will be estimated with flow cytometrie.
Time frame: after 2 days and 2 weeks of adapted diet
blood samples will be collected before and after exercise, the level of cortisol will be estimated in these blood samples
Time frame: after 2 days and 2 weeks of adapted diet
in urine will be detected with KetoStix
Time frame: after 2 days and 2 weeks of adapted diet
in blood will be detected with an ELISA
Wageningen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07552779
COVID-19, COVID-19 (Coronavirus Disease 2019)
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT04155892
Infections, Respiratory Tract Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT05577065
Infections, Respiratory Tract Diseases
Cork, Ireland
View Trial Details